VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q59694886 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010722.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q59694886‏
024 ‎‡a 0000-0002-3439-1658‏ ‎‡2 orcid‏
024 ‎‡a 47761460600‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q59694886‏
100 0 ‎‡a Isabel Veloso Alves Pereira‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Isabel Veloso Alves Pereira‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Connexin hemichannel inhibition reduces acetaminophen-induced liver injury in mice‏
670 ‎‡a Author's Connexin32: a mediator of acetaminophen-induced liver injury?‏
670 ‎‡a Author's Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis‏
670 ‎‡a Author's Connexins and pannexins in liver damage‏
670 ‎‡a Author's Connexins, Pannexins, and Their Channels in Fibroproliferative Diseases‏
670 ‎‡a Author's Erratum to: Inhibition of pannexin1 channels alleviates acetaminophen-induced hepatotoxicity‏
670 ‎‡a Author's Immunohisto- and Cytochemistry Analysis of Connexins.‏
670 ‎‡a Author's Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice‏
670 ‎‡a Author's Inhibition of pannexin1 channels alleviates acetaminophen-induced hepatotoxicity‏
670 ‎‡a Author's Involvement of connexin43 in acetaminophen-induced liver injury.‏
670 ‎‡a Author's Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).‏
670 ‎‡a Author's Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.‏
670 ‎‡a Author's Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research‏
670 ‎‡a Author's Structure, Regulation and Function of Gap Junctions in Liver.‏
909 ‎‡a (scopus) 47761460600‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000234391658‏ ‎‡9 1‏
919 ‎‡a erratumtoinhibitionofpannexin1channelsalleviatesacetaminopheninducedhepatotoxicity‏ ‎‡A Erratum to: Inhibition of pannexin1 channels alleviates acetaminophen-induced hepatotoxicity‏ ‎‡9 1‏
919 ‎‡a inhibitionofpannexin1channelsalleviatesacetaminopheninducedhepatotoxicity‏ ‎‡A Inhibition of pannexin1 channels alleviates acetaminophen-induced hepatotoxicity‏ ‎‡9 1‏
919 ‎‡a connexinspannexinsandtheirchannelsinfibroproliferativediseases‏ ‎‡A Connexins, Pannexins, and Their Channels in Fibroproliferative Diseases‏ ‎‡9 1‏
919 ‎‡a connexinsandpannexinsinliverdamage‏ ‎‡A Connexins and pannexins in liver damage‏ ‎‡9 1‏
919 ‎‡a connexin32deficiencyisassociatedwithliverinjuryinflammationandoxidativestressinexperimentalnonalcoholicsteatohepatitis‏ ‎‡A Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis‏ ‎‡9 1‏
919 ‎‡a connexin32amediatorofacetaminopheninducedliverinjury‏ ‎‡A Connexin32: a mediator of acetaminophen-induced liver injury?‏ ‎‡9 1‏
919 ‎‡a connexinhemichannelinhibitionreducesacetaminopheninducedliverinjuryinmice‏ ‎‡A Connexin hemichannel inhibition reduces acetaminophen-induced liver injury in mice‏ ‎‡9 1‏
919 ‎‡a protectiveeffectofgeneticdeletionofpannexin1inexperimentalmousemodelsofacuteandchronicliverdisease‏ ‎‡A Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.‏ ‎‡9 1‏
919 ‎‡a structureregulationandfunctionofgapjunctionsinliver‏ ‎‡A Structure, Regulation and Function of Gap Junctions in Liver.‏ ‎‡9 1‏
919 ‎‡a primarybiliaryacidsinhibithepatitis500virushdventryintohumanhepatomacellsexpressingthesodiumtaurocholatecotransportingpolypeptidentcp‏ ‎‡A Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).‏ ‎‡9 1‏
919 ‎‡a involvementofconnexin43inacetaminopheninducedliverinjury‏ ‎‡A Involvement of connexin43 in acetaminophen-induced liver injury.‏ ‎‡9 1‏
919 ‎‡a inhibitionofconnexinhemichannelsalleviatesnonalcoholicsteatohepatitisinmice‏ ‎‡A Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice‏ ‎‡9 1‏
919 ‎‡a strategiesmodelsandbiomarkersinexperimentalnonalcoholicfattyliverdiseaseresearch‏ ‎‡A Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research‏ ‎‡9 1‏
919 ‎‡a immunohistoandcytochemistryanalysisofconnexins‏ ‎‡A Immunohisto- and Cytochemistry Analysis of Connexins.‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 SUDOC|076163156‏
996 ‎‡2 BLBNB|000307936‏
996 ‎‡2 PTBNP|70644‏
996 ‎‡2 BLBNB|000554736‏
996 ‎‡2 CAOONL|ncf11949024‏
996 ‎‡2 ISNI|0000000040362058‏
996 ‎‡2 BLBNB|000399588‏
996 ‎‡2 J9U|987007362553405171‏
996 ‎‡2 NII|DA15003501‏
996 ‎‡2 PTBNP|785791‏
996 ‎‡2 PTBNP|65935‏
996 ‎‡2 ISNI|0000000070016594‏
996 ‎‡2 ISNI|0000000069017952‏
996 ‎‡2 LIH|LNB:CN_q_I;=B_h_‏
996 ‎‡2 PTBNP|1572976‏
996 ‎‡2 LC|n 94093615‏
996 ‎‡2 ISNI|0000000069614319‏
996 ‎‡2 ISNI|000000006651577X‏
996 ‎‡2 DNB|1122667310‏
996 ‎‡2 NUKAT|n 2018087282‏
996 ‎‡2 BNF|12630724‏
996 ‎‡2 BLBNB|001564933‏
996 ‎‡2 BLBNB|000486582‏
996 ‎‡2 ISNI|0000000460009824‏
996 ‎‡2 LC|no2004019755‏
996 ‎‡2 PTBNP|207371‏
996 ‎‡2 SUDOC|18497691X‏
996 ‎‡2 ISNI|0000000070999738‏
996 ‎‡2 ISNI|000000006952425X‏
996 ‎‡2 ISNI|0000000068603677‏
996 ‎‡2 ISNI|0000000078141410‏
996 ‎‡2 ISNI|0000000070313476‏
996 ‎‡2 NUKAT|nx2024105605‏
996 ‎‡2 ISNI|0000000068586870‏
996 ‎‡2 ISNI|0000000070839881‏
996 ‎‡2 DNB|143413996‏
996 ‎‡2 PTBNP|917563‏
996 ‎‡2 LC|n 2007206885‏
996 ‎‡2 NUKAT|n 2012052147‏
996 ‎‡2 ISNI|0000000052182783‏
996 ‎‡2 PTBNP|1412752‏
996 ‎‡2 SUDOC|153648996‏
996 ‎‡2 LC|n 2023250087‏
996 ‎‡2 ISNI|0000000512364503‏
996 ‎‡2 ISNI|0000000070130274‏
996 ‎‡2 PTBNP|1848982‏
996 ‎‡2 ISNI|0000000067877078‏
996 ‎‡2 DNB|14018290X‏
996 ‎‡2 PTBNP|1282109‏
996 ‎‡2 LC|no2017103804‏
996 ‎‡2 RERO|A003681701‏
996 ‎‡2 ISNI|0000000068881167‏
996 ‎‡2 NUKAT|n 2020000472‏
996 ‎‡2 PTBNP|1238389‏
996 ‎‡2 PTBNP|1515307‏
996 ‎‡2 ISNI|0000000070227826‏
996 ‎‡2 PTBNP|1384785‏
996 ‎‡2 PTBNP|1494704‏
996 ‎‡2 SUDOC|161343317‏
996 ‎‡2 PTBNP|70769‏
996 ‎‡2 PTBNP|1575265‏
996 ‎‡2 PTBNP|1043014‏
996 ‎‡2 ISNI|0000000066471180‏
996 ‎‡2 LC|nr 88002925‏
996 ‎‡2 NTA|080246826‏
996 ‎‡2 PTBNP|1494209‏
996 ‎‡2 PTBNP|196100‏
996 ‎‡2 ISNI|0000000428288472‏
996 ‎‡2 BNF|12318272‏
996 ‎‡2 BLBNB|001445283‏
996 ‎‡2 PTBNP|1588182‏
996 ‎‡2 PTBNP|1424082‏
996 ‎‡2 PTBNP|35286‏
996 ‎‡2 BNF|14127470‏
996 ‎‡2 DNB|1057482544‏
996 ‎‡2 SUDOC|244224625‏
996 ‎‡2 ISNI|0000000077873089‏
996 ‎‡2 LC|n 2007214914‏
996 ‎‡2 RERO|A006171288‏
996 ‎‡2 PTBNP|814319‏
996 ‎‡2 PTBNP|869055‏
996 ‎‡2 ISNI|0000000069015105‏
996 ‎‡2 ISNI|0000000093759112‏
996 ‎‡2 LC|no2002039208‏
996 ‎‡2 PTBNP|1224829‏
996 ‎‡2 PTBNP|281159‏
996 ‎‡2 BLBNB|001015235‏
996 ‎‡2 SUDOC|143507109‏
996 ‎‡2 SUDOC|178169528‏
996 ‎‡2 PTBNP|231011‏
996 ‎‡2 SUDOC|087180162‏
996 ‎‡2 PTBNP|1305363‏
996 ‎‡2 PTBNP|1406615‏
996 ‎‡2 LC|no2002092988‏
996 ‎‡2 PTBNP|257444‏
996 ‎‡2 DNB|1147174490‏
996 ‎‡2 ISNI|0000000428255988‏
996 ‎‡2 SUDOC|032084692‏
996 ‎‡2 ISNI|0000000068385999‏
996 ‎‡2 LC|n 2014188100‏
996 ‎‡2 PTBNP|1378295‏
996 ‎‡2 PTBNP|1517045‏
996 ‎‡2 DNB|1057752606‏
996 ‎‡2 ISNI|0000000040733170‏
996 ‎‡2 ISNI|0000000073653222‏
996 ‎‡2 ISNI|0000000067984682‏
996 ‎‡2 LC|nb2011017617‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏